bioAffinity Technologies, Inc. (BIAF)Healthcare | Diagnostics & Research | San Antonio, United States | NasdaqCM
2.78 USD
+0.09
(3.238%)
⇧
(April 21, 2026, 10:26 a.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:58 p.m. EDT
BIAF presents a severe sellers' market driven by deteriorating fundamentals: -27.8% revenue growth, negative cash flow, and a surge in stock price (+120%+) that cannot be supported by the current operational reality, leading to a sharp price correction over the last two weeks before hitting a 52-week low. With a negative forward P/E, -30% earnings growth, zero dividend history, and a model predicting a -0.8% return with high statistical noise (excess kurtosis, significant Ljung-Box), the instrument is a high-risk speculative trade with no underlying business support to sustain the rally. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.547680 |
| AutoETS | 0.548010 |
| AutoARIMA | 0.548010 |
| AutoTheta | 0.644582 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 14.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.056 |
| Excess Kurtosis | -1.63 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 15.95 |
| Revenue per Share | 3.58 |
| Market Cap | 12,493,365 |
| Forward P/E | -4.63 |
| Beta | -0.82 |
| Profit Margins | -241.96% |
| Website | https://bioaffinitytech.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.824183 |
| Address1 | 3,300 Nacogdoches Road |
| Address2 | Suite 216 |
| All Time High | 466.5 |
| All Time Low | 0.693 |
| Ask | 3.43 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 569,950 |
| Average Daily Volume3 Month | 8,845,786 |
| Average Volume | 8,845,786 |
| Average Volume10Days | 569,950 |
| Beta | -0.815 |
| Bid | 1.95 |
| Bid Size | 2 |
| Book Value | 1.619 |
| City | San Antonio |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.7771 |
| Current Ratio | 2.603 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.7771 |
| Day Low | 2.64 |
| Debt To Equity | 15.95 |
| Display Name | bioAffinity |
| Earnings Timestamp End | 1,755,174,600 |
| Earnings Timestamp Start | 1,755,174,600 |
| Ebitda | -10,067,672 |
| Ebitda Margins | -1.6338401 |
| Enterprise To Ebitda | -0.676 |
| Enterprise To Revenue | 1.104 |
| Enterprise Value | 6,800,718 |
| Eps Forward | -0.6 |
| Eps Trailing Twelve Months | -8.66 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.25652 |
| Fifty Day Average Change | 0.52058005 |
| Fifty Day Average Change Percent | 0.23070039 |
| Fifty Two Week Change Percent | -82.4183 |
| Fifty Two Week High | 16.05 |
| Fifty Two Week High Change | -13.2729 |
| Fifty Two Week High Change Percent | -0.826972 |
| Fifty Two Week Low | 0.693 |
| Fifty Two Week Low Change | 2.0841 |
| Fifty Two Week Low Change Percent | 3.0073593 |
| Fifty Two Week Range | 0.693 - 16.05 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,662,039,000,000 |
| Float Shares | 4,266,308 |
| Forward Eps | -0.6 |
| Forward P E | -4.6285 |
| Free Cashflow | -4,933,569 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 57 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.31405002 |
| Gross Profits | 1,935,160 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03263 |
| Held Percent Institutions | 0.05351 |
| Implied Shares Outstanding | 4,498,709 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Ipo Expected Date | 2,022-08-25 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,758,240,000 |
| Last Split Factor | 1:30 |
| Long Business Summary | bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas. |
| Long Name | bioAffinity Technologies, Inc. |
| Market | us_market |
| Market Cap | 12,493,365 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_423045573 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -14,909,754 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 12,146,422 |
| Open | 2.64 |
| Operating Cashflow | -9,328,842 |
| Operating Margins | -1.9694501 |
| Payout Ratio | 0.0 |
| Phone | 210 698 5334 |
| Previous Close | 2.69 |
| Price Hint | 4 |
| Price To Book | 1.7153182 |
| Price To Sales Trailing12 Months | 2.027499 |
| Profit Margins | -2.41965 |
| Quick Ratio | 2.406 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.08710003 |
| Regular Market Change Percent | 3.2379193 |
| Regular Market Day High | 2.7771 |
| Regular Market Day Low | 2.64 |
| Regular Market Day Range | 2.64 - 2.7771 |
| Regular Market Open | 2.64 |
| Regular Market Previous Close | 2.69 |
| Regular Market Price | 2.7771 |
| Regular Market Time | 1,776,781,565 |
| Regular Market Volume | 49,344 |
| Return On Assets | -0.75628 |
| Return On Equity | -3.01826 |
| Revenue Growth | -0.278 |
| Revenue Per Share | 3.58 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,498,675 |
| Shares Percent Shares Out | 0.1205 |
| Shares Short | 542,083 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 221,303 |
| Short Name | bioAffinity Technologies, Inc. |
| Short Percent Of Float | 0.1229 |
| Short Ratio | 0.02 |
| Source Interval | 15 |
| State | TX |
| Symbol | BIAF |
| Total Cash | 6,449,782 |
| Total Cash Per Share | 1.435 |
| Total Debt | 1,160,821 |
| Total Revenue | 6,161,959 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -8.66 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.812155 |
| Two Hundred Day Average Change | -1.0350549 |
| Two Hundred Day Average Change Percent | -0.2715144 |
| Type Disp | Equity |
| Volume | 49,344 |
| Website | https://bioaffinitytech.com |
| Zip | 78,217 |